Tessera Therapeutics
Tessera Therapeutics is a biotechnology company pioneering Gene Writing™ to drive advancements in genome engineering.
About Tessera Therapeutics
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
Company Facts
- Headquarters
- Cambridge
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00251_00500
- Total Funding
- $773,055,224
- Last Funding Type
- grant
- Last Funding Date
- 2026-03-23
- Website
- tesseratherapeutics.com
Industries & Categories
Biopharma, Biotechnology, Genetics, Life Science, Therapeutics
Social Links
Canonical: https://fsome.com/organization/tessera-therapeutics-22685 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.